BackAmerican Oncology Network- Warrants (20/09/2028) Overview
American Oncology Network Inc - Warrants (20/09/2028)

American Oncology Network- Warrants (20/09/2028) Return on Equity

Latest ROE for American Oncology Network- Warrants (20/09/2028): -40.67% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-40.67%

Return on Equity

-40.67%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

American Oncology Network- Warrants (20/09/2028) (AONCW) FAQ

The latest ROE for AONCW is -40.67%. That is below the sector sector average of -6.13%. Investors often review this figure alongside American Oncology Network- Warrants (20/09/2028)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, AONCW currently prints -40.67% for ROE, while the sector average sits near -6.13%. That is roughly 563.7% below the sector mean. Large gaps often invite a closer look at American Oncology Network- Warrants (20/09/2028)'s growth, margins, and balance sheet.

Return on Equity shows how effectively American Oncology Network- Warrants (20/09/2028) converts resources into returns. At -40.67%, AONCW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AONCW's ROE (-40.67%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.